{"id":10932,"date":"2026-09-29T10:00:00","date_gmt":"2026-09-29T13:00:00","guid":{"rendered":"https:\/\/artica.capital\/?post_type=pilulas&#038;p=10932"},"modified":"2026-10-20T16:47:18","modified_gmt":"2026-10-20T19:47:18","slug":"de-descoberta-cientifica-a-fenomeno-global-a-ascensao-das-canetas-emagrecedoras","status":"publish","type":"pilulas","link":"https:\/\/artica.capital\/en\/clairfield-pilulas\/de-descoberta-cientifica-a-fenomeno-global-a-ascensao-das-canetas-emagrecedoras\/","title":{"rendered":"De descoberta cient\u00edfica a fen\u00f4meno global: a ascens\u00e3o das canetas emagrecedoras"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Desde 2017, as \u201ccanetas emagrecedoras\u201d deixaram de um medicamento comum para se tornarem o centro de uma disputa comercial entre as principais farmac\u00eauticas do mundo. Cada novo resultado cl\u00ednico, dados de vendas e patente movimenta bilh\u00f5es de d\u00f3lares em valor de mercado das empresas envolvidas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Mas essa hist\u00f3ria come\u00e7ou d\u00e9cadas antes de Ozempic e Mounjaro serem usados para fins de emagrecimento. Suas origens remontam \u00e0 descoberta do GLP-1 na d\u00e9cada de 1980, passam por um curioso pept\u00eddeo identificado no monstro-de-gila e por d\u00e9cadas de pesquisa at\u00e9 chegar \u00e0 atual corrida entre Novo Nordisk e Eli Lilly.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A categoria tamb\u00e9m evoluiu rapidamente: medicamentos inicialmente desenvolvidos para diabetes avan\u00e7aram para o tratamento da obesidade e ganharam proje\u00e7\u00e3o global por seus efeitos na perda de peso.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Na p\u00edlula de hoje, revisitamos quatro d\u00e9cadas de ci\u00eancia para entender como os GLP-1 se transformaram em um fen\u00f4meno global e como essa corrida redefiniu a competi\u00e7\u00e3o e o valor de mercado de duas das maiores farmac\u00eauticas do mundo.<\/p>\n\n\n\n<!-- pilula-html v2 -->\n<style>\n.pil-deck{margin:32px 0}\n.pil-deck .pil-slide{margin:0 0 28px;overflow-x:auto;-webkit-overflow-scrolling:touch}\n.pil-deck .s{position:relative;container-type:inline-size;min-width:640px;font-family:Arial,\"Helvetica Neue\",Helvetica,sans-serif;box-shadow:0 1px 6px rgba(0,0,0,.12)}\n.pil-deck .s>img{display:block;width:100%;height:auto;margin:0}\n.pil-deck .t{position:absolute;box-sizing:border-box;display:flex;flex-direction:column;margin:0;font:inherit;letter-spacing:0;overflow:visible}\n.pil-deck .t p{margin:0;padding:0}\n.pil-deck h2.t{letter-spacing:-.015em;text-transform:none}\n.pil-deck .t sup,.pil-deck .t sub{font-size:.6em;line-height:0}\n.pil-deck .t p.b::before{content:var(--bc,\"\\2022\");display:inline-block;width:var(--bw,1.1em);text-indent:0;font-size:var(--bs,100%);color:var(--bk,inherit)}\n.pil-deck .t span{font-family:inherit}\n<\/style>\n<div class=\"pil-deck\">\n<figure class=\"pil-slide\"><div class=\"s\"><img src=\"https:\/\/artica.capital\/wp-content\/uploads\/2026\/10\/pilula-canetas-emagrecedoras-1.jpg\" alt=\"Slide 1: A ci&#234;ncia por tr&#225;s das canetas emagrecedoras come&#231;ou na d&#233;cada de 1980 e levou quase quatro d&#233;cadas at&#233; seu primeiro blockbuster, o Ozempic\" width=\"1920\" height=\"1080\" loading=\"lazy\" decoding=\"async\"><div class=\"t\" style=\"left:1.953%;top:94.975%;width:94.783%;min-height:5.26%;justify-content:center;padding:0.375% 0.75% 0.375% 0.75%;\"><p style=\"text-align:left;line-height:1.053;margin:0.0cqw 0 0cqw 0\"><span style=\"font-size:0.833cqw;color:#000000\">Fonte: Forbes; FDA; An&#225;lise &#193;rtica. (1) Ag&#234;ncia federal dos Estados Unidos respons&#225;vel por proteger e promover a sa&#250;de p&#250;blica.<\/span><\/p><\/div><h2 class=\"t\" style=\"left:1.953%;top:3.515%;width:85.087%;min-height:7.596%;justify-content:flex-start;padding:0.375% 0.75% 0.375% 0.75%;\"><p style=\"text-align:left;line-height:1.053;margin:0.0cqw 0 0cqw 0\"><span style=\"font-size:2.083cqw;color:#ffffff;font-weight:700\">A ci&#234;ncia por tr&#225;s das canetas emagrecedoras come&#231;ou na d&#233;cada de 1980 e levou quase quatro d&#233;cadas at&#233; seu primeiro blockbuster, o Ozempic<\/span><\/p><\/h2><div class=\"t\" style=\"left:82.161%;top:20.972%;width:3.75%;min-height:2.662%;justify-content:center;padding:0.0% 0.0% 0.0% 0.0%;white-space:nowrap;\"><p style=\"text-align:left;line-height:1.17;margin:0.0cqw 0 0.0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Eli Lilly<\/span><\/p><\/div><div class=\"t\" style=\"left:88.919%;top:20.972%;width:7.409%;min-height:2.662%;justify-content:center;padding:0.0% 0.0% 0.0% 0.0%;white-space:nowrap;\"><p style=\"text-align:left;line-height:1.17;margin:0.0cqw 0 0.0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Novo Nordisk<\/span><\/p><\/div><div class=\"t\" style=\"left:26.792%;top:59.664%;width:18.129%;min-height:12.117%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000;font-weight:700\">Nasce a ci&#234;ncia do GLP-1, <\/span><span style=\"font-size:1.25cqw;color:#000000\">descoberta que abre caminho para uma nova classe de medicamentos<\/span><\/p><\/div><div class=\"t\" style=\"left:29.233%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">1982 &#8211; 1987<\/span><\/p><\/div><div class=\"t\" style=\"left:33.324%;top:101.59%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">85<\/span><\/p><\/div><div class=\"t\" style=\"left:42.448%;top:101.59%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">90<\/span><\/p><\/div><div class=\"t\" style=\"left:51.571%;top:101.59%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">95<\/span><\/p><\/div><div class=\"t\" style=\"left:69.817%;top:101.59%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">0<\/span><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">5<\/span><\/p><\/div><div class=\"t\" style=\"left:78.941%;top:101.59%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">10<\/span><\/p><\/div><div class=\"t\" style=\"left:88.064%;top:101.59%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">15<\/span><\/p><\/div><div class=\"t\" style=\"left:60.694%;top:101.59%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">00<\/span><\/p><\/div><div class=\"t\" style=\"left:27.863%;top:84.801%;width:69.39%;min-height:9.828%;justify-content:center;padding:0.375% 0.0% 0.375% 2.362%;\"><p style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#2e3a4f;font-weight:700\">GLP-1 &#233; um horm&#244;nio intestinal <\/span><span style=\"font-size:1.25cqw;color:#2e3a4f\">que ajuda a controlar a glicose e aumenta a saciedade. Medicamentos reproduzem sua a&#231;&#227;o <\/span><span style=\"font-size:1.25cqw;color:#2e3a4f;font-weight:700\">reduzindo o apetite e retardando o esvaziamento g&#225;strico<\/span><span style=\"font-size:1.25cqw;color:#2e3a4f\">, favorecendo a perda de peso em at&#233; 21%<\/span><\/p><\/div><div class=\"t\" style=\"left:90.679%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">2017<\/span><\/p><\/div><div class=\"t\" style=\"left:27.863%;top:19.56%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#b7b7b7;font-weight:700;font-style:italic\">Base 100<\/span><\/p><\/div><div class=\"t\" style=\"left:27.863%;top:15.072%;width:31.75%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#2e3a4f;font-weight:700\">1980 <\/span><span style=\"font-size:1.458cqw;color:#2e3a4f;font-weight:700\">\u2013 <\/span><span style=\"font-size:1.458cqw;color:#2e3a4f;font-weight:700\">2017: Evolu&#231;&#227;o do pre&#231;o por a&#231;&#227;o<\/span><\/p><\/div><div class=\"t\" style=\"left:65.812%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">2005<\/span><\/p><\/div><div class=\"t\" style=\"left:79.257%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">2010 &#8211; 2014<\/span><\/p><\/div><div class=\"t\" style=\"left:2.765%;top:76.081%;width:21.676%;min-height:15.932%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p class=\"b\" style=\"text-align:left;line-height:1.17;margin:0.625cqw 0 0cqw 0;font-size:1.25cqw;padding-left:1.406cqw;text-indent:-1.406cqw;--bw:1.406cqw;--bc:'\\2022'\"><span style=\"font-size:1.25cqw;color:#000000\">Farmac&#234;utica dinamarquesa fundada em 1923, especializada em diabetes<\/span><\/p><p class=\"b\" style=\"text-align:left;line-height:1.17;margin:0.625cqw 0 0cqw 0;font-size:1.25cqw;padding-left:1.406cqw;text-indent:-1.406cqw;--bw:1.406cqw;--bc:'\\2022'\"><span style=\"font-size:1.25cqw;color:#000000\">Desenvolveu<\/span><span style=\"font-size:1.25cqw;color:#000000\"> medicamentos como <\/span><span style=\"font-size:1.25cqw;color:#000000\">Victoza<\/span><span style=\"font-size:1.25cqw;color:#000000\">, <\/span><span style=\"font-size:1.25cqw;color:#000000;font-weight:700;text-decoration:underline\">Ozempic<\/span><span style=\"font-size:1.25cqw;color:#000000\"> e Wegovy<\/span><\/p><\/div><div class=\"t\" style=\"left:2.765%;top:31.983%;width:21.676%;min-height:21.317%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p class=\"b\" style=\"text-align:left;line-height:1.17;margin:0.625cqw 0 0cqw 0;font-size:1.25cqw;padding-left:1.406cqw;text-indent:-1.406cqw;--bw:1.406cqw;--bc:'\\2022'\"><span style=\"font-size:1.25cqw;color:#000000\">Farmac&#234;utica americana fundada em 1876, com atua&#231;&#227;o em diabetes, oncologia, imunologia e neurologia<\/span><\/p><p class=\"b\" style=\"text-align:left;line-height:1.17;margin:0.625cqw 0 0cqw 0;font-size:1.25cqw;padding-left:1.406cqw;text-indent:-1.406cqw;--bw:1.406cqw;--bc:'\\2022'\"><span style=\"font-size:1.25cqw;color:#000000\">Desenvolveu a <\/span><span style=\"font-size:1.25cqw;color:#000000\">tirzepatida<\/span><span style=\"font-size:1.25cqw;color:#000000\">, comercializada como <\/span><span style=\"font-size:1.25cqw;color:#000000;font-weight:700;text-decoration:underline\">Mounjaro<\/span><span style=\"font-size:1.25cqw;color:#000000\"> and <\/span><span style=\"font-size:1.25cqw;color:#000000\">Zepbound<\/span><\/p><\/div><div class=\"t\" style=\"left:35.394%;top:38.754%;width:23.031%;min-height:12.117%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Pept&#237;deo identificado na saliva do monstro-de-gila inspira o <\/span><span style=\"font-size:1.25cqw;color:#000000\">exenatide<\/span><span style=\"font-size:1.25cqw;color:#000000\"> (<\/span><span style=\"font-size:1.25cqw;color:#000000\">Byetta<\/span><span style=\"font-size:1.25cqw;color:#000000\">), primeiro medicamento <\/span><span style=\"font-size:1.25cqw;color:#000000\">baseado em GLP-1 <\/span><span style=\"font-size:1.25cqw;color:#000000\">aprovado <\/span><span style=\"font-size:1.25cqw;color:#000000\">pel<\/span><span style=\"font-size:1.25cqw;color:#000000\">o<\/span><span style=\"font-size:1.25cqw;color:#000000\"> FDA<\/span><\/p><\/div><div class=\"t\" style=\"left:69.361%;top:47.154%;width:16.055%;min-height:9.424%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Novo Nordisk lan&#231;a o primeiro agonista de GLP-1, <\/span><span style=\"font-size:1.25cqw;color:#000000\">Saxenda<\/span><span style=\"font-size:1.25cqw;color:#000000\">, aprovado pelo FDA<\/span><\/p><\/div><div class=\"t\" style=\"left:76.498%;top:27.211%;width:21.986%;min-height:13.912%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">FDA<\/span><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\"><sup>(1)<\/sup><\/span><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\"> aprova o Ozempic, vers&#227;o injet&#225;vel da semaglutida para tratamento do diabetes tipo 2<\/span><\/p><\/div><\/div><\/figure>\n<figure class=\"pil-slide\"><div class=\"s\"><img src=\"https:\/\/artica.capital\/wp-content\/uploads\/2026\/10\/pilula-canetas-emagrecedoras-2.jpg\" alt=\"Slide 2: Entre 2018 e 2023, os GLP-1 saem do mercado de diabetes e viram fen&#244;meno global para perda de peso, impulsionando a demanda e as a&#231;&#245;es de Novo e Lilly\" width=\"1920\" height=\"1080\" loading=\"lazy\" decoding=\"async\"><div class=\"t\" style=\"left:1.953%;top:94.975%;width:94.783%;min-height:5.26%;justify-content:center;padding:0.375% 0.75% 0.375% 0.75%;\"><p style=\"text-align:left;line-height:1.053;margin:0.0cqw 0 0cqw 0\"><span style=\"font-size:0.833cqw;color:#000000\">Fonte: FDA; The Guardian; Forbes; Anvisa; X; An&#225;lise &#193;rtica. (1) Horm&#244;nio intestinal que tamb&#233;m estimula o controle glic&#234;mico. <\/span><\/p><\/div><h2 class=\"t\" style=\"left:1.953%;top:3.515%;width:85.087%;min-height:7.596%;justify-content:flex-start;padding:0.375% 0.75% 0.375% 0.75%;\"><p style=\"text-align:left;line-height:1.053;margin:0.0cqw 0 0cqw 0\"><span style=\"font-size:2.083cqw;color:#ffffff;font-weight:700\">Entre 2018 e 2023, os GLP-1 saem do mercado de diabetes e viram fen&#244;meno global para perda de peso, impulsionando a demanda e as a&#231;&#245;es de Novo e Lilly<\/span><\/p><\/h2><div class=\"t\" style=\"left:49.74%;top:20.949%;width:3.75%;min-height:2.662%;justify-content:center;padding:0.0% 0.0% 0.0% 0.0%;white-space:nowrap;\"><p style=\"text-align:left;line-height:1.17;margin:0.0cqw 0 0.0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Eli Lilly<\/span><\/p><\/div><div class=\"t\" style=\"left:56.497%;top:20.949%;width:7.409%;min-height:2.662%;justify-content:center;padding:0.0% 0.0% 0.0% 0.0%;white-space:nowrap;\"><p style=\"text-align:left;line-height:1.17;margin:0.0cqw 0 0.0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Novo Nordisk<\/span><\/p><\/div><div class=\"t\" style=\"left:93.376%;top:107.433%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">2017<\/span><\/p><\/div><div class=\"t\" style=\"left:2.765%;top:19.56%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#b7b7b7;font-weight:700;font-style:italic\">Base 100<\/span><\/p><\/div><div class=\"t\" style=\"left:2.765%;top:15.072%;width:29.51%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#2e3a4f;font-weight:700\">2018<\/span><span style=\"font-size:1.458cqw;color:#2e3a4f;font-weight:700\"> &#8211; 2023<\/span><span style=\"font-size:1.458cqw;color:#2e3a4f;font-weight:700\">: Evolu&#231;&#227;o do pre&#231;o por a&#231;&#227;o<\/span><\/p><\/div><div class=\"t\" style=\"left:2.791%;top:25.382%;width:19.592%;min-height:14.81%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000;font-weight:700\">Lilly publica os primeiros resultados relevantes da <\/span><span style=\"font-size:1.25cqw;color:#c00000;font-weight:700\">T<\/span><span style=\"font-size:1.25cqw;color:#c00000;font-weight:700\">irzepatida<\/span><span style=\"font-size:1.25cqw;color:#000000\">, <\/span><span style=\"font-size:1.25cqw;color:#000000\">que combina a a&#231;&#227;o do<\/span><span style=\"font-size:1.25cqw;color:#000000\"> GIP<\/span><span style=\"font-size:1.25cqw;color:#000000\"><sup>(1)<\/sup><\/span><span style=\"font-size:1.25cqw;color:#000000\"> e GLP-1, mais tarde originando o Mounjaro e <\/span><span style=\"font-size:1.25cqw;color:#000000\">Zepbound<\/span><\/p><\/div><div class=\"t\" style=\"left:18.292%;top:44.277%;width:20.208%;min-height:12.117%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">A FDA aprova o Wegovy para tratamento de obesidade, <\/span><span style=\"font-size:1.25cqw;color:#000000;font-weight:700\">ampliando o uso dos GLP-1 para al&#233;m do diabetes<\/span><\/p><\/div><div class=\"t\" style=\"left:68.558%;top:77.014%;width:28.036%;min-height:9.424%;justify-content:flex-start;padding:0.379% 0.0% 0.379% 0.758%;\"><p style=\"text-align:left;line-height:1.17;margin:0cqw 0 1.25cqw 0\"><span style=\"font-size:1.25cqw;color:#262626;font-weight:700;font-style:italic\">Busca por Ozempic para perda de peso leva a escassez do medicamento para diab&#233;ticos nos EUA<\/span><\/p><\/div><div class=\"t\" style=\"left:85.666%;top:88.331%;width:10.401%;min-height:4.015%;justify-content:flex-start;padding:0.379% 0.758% 0.379% 0.758%;\"><p style=\"text-align:right;line-height:1.053;margin:0.625cqw 0 0cqw 0\"><span style=\"font-size:1.146cqw;color:#000000;font-style:italic\">Mar&#231;o 2023<\/span><\/p><\/div><div class=\"t\" style=\"left:72.704%;top:21.131%;width:19.57%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#2e3a4f;font-weight:700\">A demanda supera a oferta<\/span><\/p><\/div><div class=\"t\" style=\"left:36.894%;top:29.162%;width:19.429%;min-height:12.117%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Devido ao sucesso, Wegovy entra na <\/span><span style=\"font-size:1.25cqw;color:#000000;font-weight:700\">lista de desabastecimento do FDA <\/span><span style=\"font-size:1.25cqw;color:#000000\">em mar&#231;o, seguido pelo Ozempic em agosto<\/span><\/p><\/div><div class=\"t\" style=\"left:2.765%;top:84.801%;width:62.008%;min-height:9.828%;justify-content:center;padding:0.375% 0.75% 0.375% 2.953%;\"><p style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#2e3a4f\">A escassez revela um novo desafio competitivo: al&#233;m de desenvolver o melhor medicamento, Novo e Lilly precisariam <\/span><span style=\"font-size:1.25cqw;color:#2e3a4f;font-weight:700\">construir capacidade para atender uma demanda muito maior do que a inicialmente prevista<\/span><\/p><\/div><div class=\"t\" style=\"left:-3.386%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">201<\/span><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">8<\/span><\/p><\/div><div class=\"t\" style=\"left:-16.605%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">2010 &#8211; 2014<\/span><\/p><\/div><div class=\"t\" style=\"left:21.773%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">2020<\/span><\/p><\/div><div class=\"t\" style=\"left:39.985%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">2022<\/span><\/p><\/div><div class=\"t\" style=\"left:68.2%;top:26.834%;width:28.579%;min-height:12.117%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p class=\"b\" style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0;font-size:1.25cqw;padding-left:1.406cqw;text-indent:-1.406cqw;--bw:1.406cqw;--bc:'\\2022'\"><span style=\"font-size:1.25cqw;color:#000000\">Ozempic vira fen&#244;meno cultural ao impulsionar a perda de peso por meio da redu&#231;&#227;o do apetite, ampliando a demanda para al&#233;m do diabetes, com o uso endossado por grandes celebridade<\/span><\/p><\/div><div class=\"t\" style=\"left:13.213%;top:55.872%;width:9.532%;min-height:6.732%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Ozempic chega ao Brasil<\/span><\/p><\/div><div class=\"t\" style=\"left:68.2%;top:64.749%;width:28.579%;min-height:9.424%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p class=\"b\" style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0;font-size:1.25cqw;padding-left:1.406cqw;text-indent:-1.406cqw;--bw:1.406cqw;--bc:'\\2022'\"><span style=\"font-size:1.25cqw;color:#000000\">A populariza&#231;&#227;o do medicamento superou as expectativas do mercado, levando &#224; escassez do produto nos EUA por meses<\/span><\/p><\/div><div class=\"t\" style=\"left:69.292%;top:59.611%;width:13.033%;min-height:3.702%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.094cqw;color:#7e7e7e;font-style:italic\">Serena Williams<\/span><\/p><\/div><div class=\"t\" style=\"left:82.614%;top:59.611%;width:13.033%;min-height:3.702%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.094cqw;color:#7e7e7e;font-style:italic\">Elon Musk<\/span><\/p><\/div><div class=\"t\" style=\"left:53.542%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">Nov<\/span><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">\u2013<\/span><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">23<\/span><\/p><\/div><div class=\"t\" style=\"left:55.355%;top:63.677%;width:9.621%;min-height:7.629%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">FDA aprova <\/span><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">Zepbound<\/span><\/p><\/div><div class=\"t\" style=\"left:8.86%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">201<\/span><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">9<\/span><\/p><\/div><\/div><\/figure>\n<figure class=\"pil-slide\"><div class=\"s\"><img src=\"https:\/\/artica.capital\/wp-content\/uploads\/2026\/10\/pilula-canetas-emagrecedoras-3.jpg\" alt=\"Slide 3: Com a Lilly ganhando terreno, a disputa pela lideran&#231;a dos GLP-1 entra em uma nova fase, com o Brasil emergindo como um dos mercados mais relevantes dessa corrida\" width=\"1920\" height=\"1080\" loading=\"lazy\" decoding=\"async\"><div class=\"t\" style=\"left:22.005%;top:49.213%;width:4.128%;min-height:2.407%;justify-content:flex-end;padding:0.0% 0.182% 0.0% 0.182%;white-space:nowrap;\"><p style=\"text-align:center;line-height:1.053;margin:0.0cqw 0 0.0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">20.228<\/span><\/p><\/div><div class=\"t\" style=\"left:0.703%;top:42.292%;width:4.128%;min-height:2.407%;justify-content:flex-end;padding:0.0% 0.182% 0.0% 0.182%;white-space:nowrap;\"><p style=\"text-align:center;line-height:1.053;margin:0.0cqw 0 0.0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">26.256<\/span><\/p><\/div><div class=\"t\" style=\"left:0.703%;top:51.204%;width:4.128%;min-height:2.407%;justify-content:flex-end;padding:0.0% 0.182% 0.0% 0.182%;white-space:nowrap;\"><p style=\"text-align:center;line-height:1.053;margin:0.0cqw 0 0.0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">18.508<\/span><\/p><\/div><div class=\"t\" style=\"left:62.982%;top:62.176%;width:3.438%;min-height:2.407%;justify-content:flex-end;padding:0.0% 0.182% 0.0% 0.182%;white-space:nowrap;\"><p style=\"text-align:center;line-height:1.053;margin:0.0cqw 0 0.0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">8.951<\/span><\/p><\/div><div class=\"t\" style=\"left:15.378%;top:30.255%;width:5.729%;min-height:3.773%;justify-content:center;padding:0.0% 0.0% 0.0% 0.0%;white-space:nowrap;\"><p style=\"text-align:center;line-height:1.17;margin:0.0cqw 0 0.0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000;font-weight:700\">-39,9%<\/span><\/p><\/div><div class=\"t\" style=\"left:1.953%;top:94.975%;width:94.783%;min-height:5.26%;justify-content:center;padding:0.375% 0.75% 0.375% 0.75%;\"><p style=\"text-align:left;line-height:1.053;margin:0.0cqw 0 0cqw 0\"><span style=\"font-size:0.833cqw;color:#000000\">Fonte: The Guardian; Yahoo Finance; Forbes; <\/span><span style=\"font-size:0.833cqw;color:#000000\">Brazil<\/span><span style=\"font-size:0.833cqw;color:#000000\"> <\/span><span style=\"font-size:0.833cqw;color:#000000\">Journal<\/span><span style=\"font-size:0.833cqw;color:#000000\">; <\/span><span style=\"font-size:0.833cqw;color:#000000\">NielsenIQ<\/span><span style=\"font-size:0.833cqw;color:#000000\">; &#201;poca Neg&#243;cios; CNN Brasil; <\/span><span style=\"font-size:0.833cqw;color:#000000\">Invest<\/span><span style=\"font-size:0.833cqw;color:#000000\"> News; <\/span><span style=\"font-size:0.833cqw;color:#000000\">An&#225;lise &#193;rtica.<\/span><\/p><\/div><h2 class=\"t\" style=\"left:1.953%;top:3.515%;width:85.087%;min-height:7.596%;justify-content:flex-start;padding:0.375% 0.75% 0.375% 0.75%;\"><p style=\"text-align:left;line-height:1.053;margin:0.0cqw 0 0cqw 0\"><span style=\"font-size:2.083cqw;color:#ffffff;font-weight:700\">Com a Lilly ganhando terreno, a disputa pela lideran&#231;a dos GLP-1 entra em uma nova fase, com o Brasil emergindo como um dos mercados mais relevantes dessa corrida<\/span><\/p><\/h2><div class=\"t\" style=\"left:49.74%;top:20.949%;width:3.75%;min-height:2.662%;justify-content:center;padding:0.0% 0.0% 0.0% 0.0%;white-space:nowrap;\"><p style=\"text-align:left;line-height:1.17;margin:0.0cqw 0 0.0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Eli Lilly<\/span><\/p><\/div><div class=\"t\" style=\"left:56.497%;top:20.949%;width:7.409%;min-height:2.662%;justify-content:center;padding:0.0% 0.0% 0.0% 0.0%;white-space:nowrap;\"><p style=\"text-align:left;line-height:1.17;margin:0.0cqw 0 0.0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Novo Nordisk<\/span><\/p><\/div><div class=\"t\" style=\"left:93.376%;top:107.433%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">2017<\/span><\/p><\/div><div class=\"t\" style=\"left:2.765%;top:19.56%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#b7b7b7;font-weight:700;font-style:italic\">Base 100<\/span><\/p><\/div><div class=\"t\" style=\"left:2.765%;top:15.072%;width:31.298%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#2e3a4f;font-weight:700\">2024<\/span><span style=\"font-size:1.458cqw;color:#2e3a4f;font-weight:700\"> &#8211; 2026: Evolu&#231;&#227;o do pre&#231;o por a&#231;&#227;o<\/span><\/p><\/div><div class=\"t\" style=\"left:1.211%;top:23.33%;width:23.793%;min-height:6.732%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000;font-weight:700\">Novo Nordisk atinge pico hist&#243;rico e supera US$ 650 bi em valor de mercado<\/span><\/p><\/div><div class=\"t\" style=\"left:69.945%;top:21.131%;width:23.63%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#2e3a4f;font-weight:700\">Canetas emagrecedoras no Brasil<\/span><\/p><\/div><div class=\"t\" style=\"left:13.092%;top:57.778%;width:21.629%;min-height:14.81%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">CagriSema<\/span><span style=\"font-size:1.25cqw;color:#000000\">, candidato para suceder o Wegovy, registra baixo desempenho, intensificando a corre&#231;&#227;o das a&#231;&#245;es da Novo, que encerram o ano ~40% abaixo do pico de <\/span><span style=\"font-size:1.25cqw;color:#000000\">jul<\/span><span style=\"font-size:1.25cqw;color:#000000\">\/24 <\/span><\/p><\/div><div class=\"t\" style=\"left:2.765%;top:84.801%;width:62.008%;min-height:9.828%;justify-content:center;padding:0.375% 0.75% 0.375% 2.953%;\"><p style=\"text-align:left;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#2e3a4f;font-weight:700\">P&#237;lulas e mol&#233;culas de pr&#243;xima gera&#231;&#227;o podem redefinir a disputa entre Novo e Lilly <\/span><span style=\"font-size:1.25cqw;color:#2e3a4f\">nos pr&#243;ximos anos. Enquanto isso, a <\/span><span style=\"font-size:1.25cqw;color:#2e3a4f;font-weight:700\">Novo busca novas avenidas de crescimento, incluindo tratamentos para calv&#237;cie<\/span><span style=\"font-size:1.25cqw;color:#2e3a4f\">, que podem representar uma nova fronteira para a companhia<\/span><\/p><\/div><div class=\"t\" style=\"left:-16.605%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">2010 &#8211; 2014<\/span><\/p><\/div><div class=\"t\" style=\"left:17.283%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">Dez-24<\/span><\/p><\/div><div class=\"t\" style=\"left:5.755%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">Jul-24<\/span><\/p><\/div><div class=\"t\" style=\"left:31.251%;top:24.868%;width:32.603%;min-height:9.424%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">O primeiro grande estudo comparativo demonstrou a <\/span><span style=\"font-size:1.25cqw;color:#000000;font-weight:700\">superioridade da <\/span><span style=\"font-size:1.25cqw;color:#000000;font-weight:700\">T<\/span><span style=\"font-size:1.25cqw;color:#000000;font-weight:700\">irzepatida<\/span><span style=\"font-size:1.25cqw;color:#000000;font-weight:700\">, da Lilly<\/span><span style=\"font-size:1.25cqw;color:#000000\">, na perda de peso, <\/span><span style=\"font-size:1.25cqw;color:#000000;font-weight:700\">consolidando a companhia como l&#237;der do mercado<\/span><\/p><\/div><div class=\"t\" style=\"left:102.402%;top:26.204%;width:26.575%;min-height:13.239%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p class=\"b\" style=\"text-align:left;line-height:1.17;margin:0.625cqw 0 0cqw 0;font-size:1.25cqw;padding-left:1.406cqw;text-indent:-1.406cqw;--bw:1.406cqw;--bc:'\\2022'\"><span style=\"font-size:1.25cqw;color:#000000\">As vendas de GLP-1 cresceram 110% em 12 meses, alcan&#231;ando R$ 14,6 bilh&#245;es<\/span><\/p><p class=\"b\" style=\"text-align:left;line-height:1.17;margin:0.625cqw 0 0cqw 0;font-size:1.25cqw;padding-left:1.406cqw;text-indent:-1.406cqw;--bw:1.406cqw;--bc:'\\2022'\"><span style=\"font-size:1.25cqw;color:#000000\">A categoria j&#225; representa 5,7% de todo o mercado de medicamentos no Brasil<\/span><\/p><\/div><div class=\"t\" style=\"left:48.673%;top:65.814%;width:15.945%;min-height:6.732%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Queda da patente de semaglutida no Brasil<\/span><\/p><\/div><div class=\"t\" style=\"left:46.106%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">Mar-26<\/span><\/p><\/div><div class=\"t\" style=\"left:28.715%;top:78.272%;width:13.247%;min-height:4.488%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.458cqw;color:#000000;font-weight:700\">Mai-25<\/span><\/p><\/div><div class=\"t\" style=\"left:78.581%;top:28.673%;width:18.307%;min-height:9.424%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0.625cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Crescimento das vendas de GLP-1 em 12 meses, chegando a R$ 14,6 bi em vendas<\/span><\/p><\/div><div class=\"t\" style=\"left:68.455%;top:68.282%;width:9.114%;min-height:8.527%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0.625cqw 0 0cqw 0\"><span style=\"font-size:3.333cqw;color:#2e3a4f;font-weight:700\">4,6<\/span><span style=\"font-size:1.458cqw;color:#2e3a4f;font-weight:700\">%<\/span><\/p><\/div><div class=\"t\" style=\"left:78.581%;top:43.628%;width:18.307%;min-height:6.732%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0.625cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Pa&#237;s que mais procura por Ozempic e Mounjaro no mundo<\/span><\/p><\/div><div class=\"t\" style=\"left:78.581%;top:56.496%;width:18.307%;min-height:6.732%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0.625cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">De todo os medicamentos vendidos no pa&#237;s<\/span><\/p><\/div><div class=\"t\" style=\"left:78.581%;top:66.672%;width:18.307%;min-height:12.117%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0.625cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Dos domic&#237;lios brasileiros consomem algum tipo de medicamento para perda de peso<\/span><\/p><\/div><div class=\"t\" style=\"left:68.455%;top:81.335%;width:9.114%;min-height:8.527%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0.625cqw 0 0cqw 0\"><span style=\"font-size:3.333cqw;color:#2e3a4f;font-weight:700\">9<\/span><\/p><\/div><div class=\"t\" style=\"left:78.581%;top:78.194%;width:18.307%;min-height:14.81%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:left;line-height:1.17;margin:0.625cqw 0 0cqw 0\"><span style=\"font-size:1.25cqw;color:#000000\">Medicamentos nacionais a base de semaglutida aprovados pela Anvisa desde a queda da patente em Mar-26<\/span><\/p><\/div><div class=\"t\" style=\"left:68.455%;top:29.121%;width:9.114%;min-height:8.527%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0.625cqw 0 0cqw 0\"><span style=\"font-size:3.333cqw;color:#2e3a4f;font-weight:700\">110<\/span><span style=\"font-size:1.458cqw;color:#2e3a4f;font-weight:700\">%<\/span><\/p><\/div><div class=\"t\" style=\"left:68.455%;top:42.175%;width:9.114%;min-height:8.527%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0.625cqw 0 0cqw 0\"><span style=\"font-size:3.333cqw;color:#2e3a4f;font-weight:700\">2<\/span><span style=\"font-size:3.333cqw;color:#000000\">&#176;<\/span><\/p><\/div><div class=\"t\" style=\"left:68.455%;top:55.228%;width:9.114%;min-height:8.527%;justify-content:center;padding:0.375% 0.0% 0.375% 0.0%;\"><p style=\"text-align:center;line-height:1.17;margin:0.625cqw 0 0cqw 0\"><span style=\"font-size:3.333cqw;color:#2e3a4f;font-weight:700\">5,7<\/span><span style=\"font-size:1.458cqw;color:#2e3a4f;font-weight:700\">%<\/span><\/p><\/div><div class=\"t\" style=\"left:48.128%;top:48.241%;width:17.793%;min-height:8.597%;justify-content:center;padding:0.375% 0.75% 0.375% 0.75%;\"><p style=\"text-align:center;line-height:1.17;margin:0cqw 0 0cqw 0\"><span style=\"font-size:1.042cqw;color:#000000\">Hoje a Lilly vale aproximadamente UD$ 1,1 tri, enquanto a novo vale US$ 170 bi<\/span><\/p><\/div><\/div><\/figure>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Desde 2017, as \u201ccanetas emagrecedoras\u201d deixaram de um medicamento comum para se tornarem o centro de uma disputa comercial entre as principais farmac\u00eauticas do mundo. Cada novo resultado cl\u00ednico, dados de vendas e patente movimenta bilh\u00f5es de d\u00f3lares em valor de mercado das empresas envolvidas. Mas essa hist\u00f3ria come\u00e7ou d\u00e9cadas antes de Ozempic e Mounjaro [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":10904,"template":"","meta":[],"class_list":["post-10932","pilulas","type-pilulas","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/artica.capital\/en\/wp-json\/wp\/v2\/pilulas\/10932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/artica.capital\/en\/wp-json\/wp\/v2\/pilulas"}],"about":[{"href":"https:\/\/artica.capital\/en\/wp-json\/wp\/v2\/types\/pilulas"}],"author":[{"embeddable":true,"href":"https:\/\/artica.capital\/en\/wp-json\/wp\/v2\/users\/4"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/artica.capital\/en\/wp-json\/wp\/v2\/media\/10904"}],"wp:attachment":[{"href":"https:\/\/artica.capital\/en\/wp-json\/wp\/v2\/media?parent=10932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}